These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 22145381)

  • 1. [The extent of coronary stenosis and the level of antibodies to atherogenic lipoproteins in patients with coronary heart disease].
    Urazgil'deeva SA; Titkov AIu; Vasina LV; Tsaregorodtseva VV; Gurevich VS
    Ter Arkh; 2011; 83(9):10-3. PubMed ID: 22145381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
    Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
    Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodetection of modified lipoproteins in plasma and arterial walls of patients with coronary heart disease.
    Sima A; Stancu C; Starodub O; Cristea C; Simionescu M
    Rom J Intern Med; 1997; 35(1-4):29-38. PubMed ID: 9562650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-traumatic dynamic changes in the antibody titer against oxidized low density lipoproteins.
    Wildburger R; Borović S; Zarković N; Tatzber F
    Wien Klin Wochenschr; 2000 Sep; 112(18):798-803. PubMed ID: 11072668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease--inverse correlation.
    Bakalova R; Zhelev Z; Goudev A; Ribarov S; Nachev C
    Gen Physiol Biophys; 1999 Mar; 18(1):87-97. PubMed ID: 10378123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty.
    Eber B; Schumacher M; Tatzber F; Kaufmann P; Luha O; Esterbauer H; Klein W
    Cardiology; 1994; 84(4-5):310-5. PubMed ID: 8187118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG; Tertov VV; Orekhov AN
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
    Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
    Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the contents of serum HDL subclasses and the extent of coronary stenosis in coronary heart disease patients].
    Xu YX; Fu MD; Xu YH; Yang LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):500-2. PubMed ID: 15291110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex link between oxidised low-density lipoprotein and unstable angina.
    Niccoli G; Mongiardo R; Lanza GA; Ricco A; Burzotta F; Trani C; Mazzari MA; Liuzzo G; Lombardo A; Rebuzzi AG; Holvoet P; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease.
    Luoma JS; Kareinen A; Närvänen O; Viitanen L; Laakso M; Ylä-Herttuala S
    Free Radic Biol Med; 2005 Dec; 39(12):1660-5. PubMed ID: 16298691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of atherosclerosis risk factors in development of ischemic heart disease in young men].
    Ezhov MV; Afanas'eva OI; Kambegova AA; Afanas'eva MI; Trukhacheva EP; Naumov VG; Pokrovskiĭ SN
    Ter Arkh; 2009; 81(5):50-4. PubMed ID: 19537587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
    Liang KW; Huang JL; Kao CH; Hsueh CW; Ho HY; Lee WL; Wang KY; Huang DS; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of myocardial perfusion abnormalities in patients with varying degree of coronary artery stenosis.
    Rasulova N; Singh A; Demetriadou O; Georgiou G; Yiannakkaras C; Khodjibekov M; Al-Nahhas A
    Nucl Med Commun; 2008 Feb; 29(2):129-36. PubMed ID: 18094634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.